Recently Rated:
Stats
Location: Rio de Janeiro, Rio de Janeiro
Work interests:
Affiliation/website:
Preferred contact method: Reply to post in blog/forum/group
Preferred contact language(s):
Contact:
Favourite publications:
Work interests:
Affiliation/website:
Preferred contact method: Reply to post in blog/forum/group
Preferred contact language(s):
Contact:
Favourite publications:
Founding Member
Location: Rio de Janeiro, Brazil
Work: 1. Hands on experience in the synthesizing the Inorganic (Ruthenium Complexes) and Heterocyclic compounds for possible biological activity. 2. Anticancer activity 3. QSAR study 4. In vitro studies including DPPH, hydroxyl radical, reducing power, total phenolic content, super oxide, hydroperoxide, nitric oxide radicals, lipid peroxidation, etc., and in vivo studies including TBARS, reduced GSH, CAT, SOD, total protein, etc. 5. Working with animal models including mice and rats for various pharmacological studies. 6. Hands on experience with analytical tools including Colorimeter, UV-Vis Spectrophotometer, TLC technique, and HPLC.
Affiliations: PRESENT AFFILIATION: Dr. SREEKANTH THOTA M.Pharmacy., Ph.D. PDF (USA) Visiting Professor, CAPES-Fiocruz/CDTS Centre for Technological Development in Health, Oswaldo Cruz Foundation (Fiocruz) Building "Expansão", 8th floor - room 814 Av. Brasil 4036 - Manguinhos Rio de Janeiro, RJ 21040-361 Brazil. sthota@cdts.fiocruz.br thota@colostate.edu stsreekanththota@gmail.com Work +55-21-3882-9234 Cell +55-21-979-555-328 Fax +55-21-2290-0494 PAST AFFILIATION: COLORADO STATE UNIVERSITY, Department of Chemistry, Colorado State University Address Fort Collins, Colorado 80523-1872.
Contact: Dr. SREEKANTH THOTA M.Pharmacy., Ph.D. PDF (USA) Visiting Professor, CAPES-Fiocruz/CDTS Centre for Technological Development in Health, Oswaldo Cruz Foundation (Fiocruz) Building "Expansão", 8th floor - room 814 Av. Brasil 4036 - Manguinhos Rio de Janeiro, RJ 21040-361 Brazil. sthota@cdts.fiocruz.br stsreekanththota@gmail.com Work +55-21-3882-9234 Cell +55-21-979-555-328 Fax +55-21-2290-0494
Biographical: Dr. SREEKANTH THOTA M.Pharmacy., Ph.D. PDF (USA) Visiting Professor, National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN) Centre for Technological Development in Health, Oswaldo Cruz Foundation (Fiocruz) Building "Expansão", 8th floor - room 814 Av. Brasil 4036 - Manguinhos Rio de Janeiro, RJ 21040-361 Brazil. sthota@cdts.fiocruz.br thota@colostate.edu stsreekanththota@gmail.com Work +55-21-3882-9234 Cell +55-21-979555328 Fax +55-21-2290-0494 Permanent address India: # 17-4-100 Kareemabad, Warangal-506002 Andhra Pradesh INDIA. EDUCATION AND RESEARCH TRAINING: • 2013 Worked as a Postdoctoral Research Scholar at Colorado State University, Fortcollins, Colorado-80521, USA. • 2006-2011 Ph.D at Jawaharlal Nehru Technological University Hyderabad, Research & Development cell, Kukatpally, Hyderabad-500085 (India). • 2004-2006, M.Pharm, Pharmaceutical Chemistry, K.L.E.S’s College of Pharmacy, Bangalore, Rajiv Gandhi University of Health sciences (India). • 1999-2003, B.Pharm, Talla Padmavathi College of Pharmacy, Kakatiya University, Warangal, (India). Professional Teaching Experience: 2006 to till date 1. Serving as a Full time Visiting Scientist in National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Centre for Technological Development in Health, Fiocruz, Rio de Janeiro, Brasil from September 2014 to till date. 2. Served as Full time Associate Professor, Head of the Department for Pharmaceutical Chemistry at S. R. College of Pharmacy, Ananthasagar, Warangal, India. (November-2013 to August-2014 ) 3. Worked as a Postdoctoral Research Scholar in Colorado State University, Department of Chemistry and Molecular Sciences. (2013) 4. Served as Full time Associate Professor, Head of the Department for Pharmaceutical Chemistry at S. R. College of Pharmacy, Ananthasagar, Warangal, India. (April-2011 to 2013) 5. Served as Assistant. Professor, at S .R. College of Pharmacy, Ananthasagar, Warangal, India. (August-2008 to July-2010) 6. Served as a Lecturer/Assistant Professor, at Blue Birds College of Pharmacy, Bheemaram Warangal. (June-2006 to July 2008) Research projects working/ worked 1. Cu-Peptide complexes triggering effect on the protein aggregation. 2. Design, Synthesis, Characterization, Anticancer and Quantitaive Structure Activity relationship of some novel 1,3,4-thiadiazole derivatives. 3. Synthesis, characterization and QSAR studies of novel pyrazole derivatives. 4. Synthesis, Spectroscopic Characterization and Antitumor activities of certain novel mononuclear Ru(II) complexes. 5. Design, Synthesis, Characerization, antiviral and antimicrobial activities of novel imidazo (2, 1-b)-Thiadiazole derivatives. 6. Synthesis, Spectroscopic Characterization and Antioxidant and Antimicrobial activities of novel quinazoline derivatives. Collaborative Research: 1. INCT-IDN, National Institute of Science and Technology of innovation in neglected diseases. Rio de Janeiro, Brazil. 2. National Institute of Health, Bethesda, USA. 3. Prof. Eliezer J. Barreiro, LASSBio, UFRJ, Cidade Universitaria, Rio de Janeiro, Brazil. 4. Prof. Dr. Erick De Clercq, Rega Institute for Medical Research, minderbroedersstraat, 10, B-3000, Leuven, Belgium. 5. Prof. Debbie C Crans, Department of Chemistry, Colorado State University, USA. 6. Dept. of Engineering Physics, MS Ramaiah College of Engineering, Bangalore. 4. Dr. Sathees Raghavan, Assistant Professor, Biochemistry Dept. Indian Institute of Science, Bangalore. AWARDS AND FELLOWSHIPS « Receipient of Visiting Professor fellowship from National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Centre for Technological Development in Health, Fiocruz, Rio de Janeiro, Brasil. (2014-2018) « Postdoctoral fellowship from Colorado State University, Colorado, Fortcollins, USA. (2013) « Recepient of “RESEARCH PROMOTION SCHEME” AICTE Project fellowship, Principal Investigator, India. « DST-SERC Young Scientist Award, INDIA. « Associate Editor for International Journals. Reviewer for the following journals: 1. American Chemical Society Journals 2. Journal of molecular structure 3. Journal of Microbiology and Antimicrobials 4. European Journal of Medicinal Chemistry 5. Journal of Coordinaion Chemistry 6. Asian Journal of Pharmaceutical and Biological Research 7. Several Indian journals etc… Presentation of Papers at Conferences / Seminars: 1. Presented poster paper on “Synthesis and in-vitro anticancer activity of some novel mononuclear Ru(II) complexes” T. Sreekanth, Subhas S Karki, at 2nd International conference on Drug Design and Process Research” held at KLES College of Pharmacy, Belgaum, Karnataka, India, 10-12, February 2006. 2. Presented poster paper on “Synthesis, characterization and pharmacological activities of some novel mononuclear Ru(II) complexes” T. Sreekanth, Subhas S Karki, at Emerging trends in pharmaceutical sciences, AICTE sponsored program, held at M.N.R.College of pharmacy, Sangareddy, HYDERABAD, India, 27-28, Febrauary 2009. 3. presented oral paper on “Synthesis, characterisation and In-vitro cytotoxicactivities of some Ru(II) complexes” T. Sreekanth, Subhas S Karki, at 14th Annual Green Chemistry & Engineering Conference, held at Capital Hilton, 1001 16th St. NW, Washington, DC 20036. U.S.A. june 21-23, 2010. 4. Synthesis, spectral characterization antioxidant and antimicrobial activities of some novel mononuclear Ru(II)complexes. Mohammad Imran, Sreekanth Thota, B.Rajanarender, Y.Rajeshwar. AAPS, NIPER, September 3rd -4th 2011. 5. Synthesis, spectroscopic characterization, in vitro antitumor and antibacterial activity of Ru(II) complexes. T. Sreekanth, Md. Imran, U. Manasa, Y. Rajeshwar, Subhas S Karki, Jan Balzarini & Erik De Clercq. National Symposium on “Recent Trends in Pharmacy Education and Industry” 11th February, 2012. 6. An overview of Microwave Assisted Green Synthesis, M. Sravani, A. Naresh, A. Navitha, T.Sreekanth & Y. Rajeshwar. National Symposium on “Recent Trends in Pharmacy Education and Industry” 11th February, 2012. 7. In vitro Antioxidant activity of some novel synthetic mononuclear Ru(II) compounds. A. Shyam Sunder, T. Sreekanth, Y. Rajeshwar & D. Satyavathi. National Symposium on “Recent Trends in Pharmacy Education and Industry” 8. Synthesis, spectroscopic characterization and invitro cytotoxic activities of novel mononuclear Ru(II)complexes. T. Sreekanth, Md. Imran, Jan Balzarini, Erik De Clercq & Y. Rajeshwar. 63rd IPC-Bangalore. 9. Synthesis, spectroscopic characterization and in vitro cytotoxic activities of mononuclear Ru(II) complexes. T. Sreekanth, Md. Imran, U. Manasa, Y. Rajeshwar, Subhas S Karki, Jan Balzarini & Erik De Clercq. American Chemical Society, Division of Medicinal Chemistry, 243rd National Meeting & Exposition. March 25-29, 2012, sandiego, california. Accepted paper and published in online abstract book. 10. Synthesis, characterization antioxidant & antimicrobial activities of some novel Pyrazoline derivatives. T. Sreekanth, Md. Imran, U. Manasa, Y. Rajeshwar, Subhas S Karki, Jan Balzarini & Erik De Clercq. American Chemical Society, Division of Medicinal Chemistry, 243rd National Meeting & Exposition. March 25-29, 2012, sandiego, california. Published in online abstract book. 11. Design, Synthesis, characterization and in-vitro anticancer activitiy of novel Ru(II) complexes. Sreekanth Thota, Sravani Mekala, Anusha Shenkesi, Rajeshwar Yerra, Subhas S Karki, Jan Balzarini & Erik De Clercq. IPC-2012. Accepted Paper. 12. Design, Synthesis, and biological evaluation of a novel 1,3,4-thiadiazole derivatives as anti-inflammatory and anti microbial agents. Sreekanth Thota, Sravani Mekala, Anusha Shenkesi, Rajeshwar Yerra, Subhas S Karki, Jan Balzarini & Erik De Clercq. IPC-2012. Accepted Paper. 13. Antinociceptive activity of novel synthetic mononuclear Ruthenium(II) compounds. Shyam Sunder Anchuri, Sreekanth Thota, Rajeshwar Yerra, Satyavathi Dhulipala and P. Sowmya. 14. Development of novel potential Antineoplastic agents. Sreekanth Thota, Rajeshwar Yerra, Debbie C Crans. “Translational Science at fiocruz, Building international Collaborations” Brazil, Riode Janerio, December 2-6th, 2013. 15. Synthesis, Characetrization and Invitro cytotxic activity of some Ru(II) complexes. Srujana Vallala, Rajeshwar Yerra, Sreekanth Thota, Jan Balzarini, Erik De Clercq. International conference on Drugs for the Future: Infectious Diseases. Antimicrobial Drug Discovery: Challenges and Perspectives. NIPER, Hyderabad, March 27-28th, 2014. 16. Design, Synthesis and spectroscopic characterization of novel 1,3,4-thiadiazole derivatives as Antimicrobial agents. Sreekanth Thota, Rajeshwar Yerra. International conference on Drugs for the Future: Infectious Diseases. Antimicrobial Drug Discovery: Challenges and Perspectives. NIPER, Hyderabad, March 27-28th, 2014. 17. “New Strategies for Research and Development”. Sreekanth Thota, Carlos M. Morel. 9th European Congress on Tropical Medicine and International Health which will take place in Basel, Switzerland from 6 -10 September 2015. Accepted Poster Presentation. PUBLISHED BOOKS: 1. Ruthenium complexes as Anticancer agents, T. Sreekanth, S. S. Karki, Y. Rajeshwar. ISBN NO. 978-3-65912485-3. Lambert academic publications. Germany. 2012 2. “Inorganic Cordination chemistry of Vanadium”, D.C.Crans, T. Sreekanth, Comprehensive Inorganic Chemistry, Book Chapter, accepted in September-2014. 3. Ruthenium compounds as Antineoplastic agents, T. Sreekanth, S. S. Karki, Y. Rajeshwar. . ISBN NO. 978-3-8454-0404-2. Lambert academic publications. Germany. 2014. 4. “Metal Nanoparticles in Drug Discovery” Sreekanth Thota, Wiley-VCH Verlag GmbH & Co. KGaA, Germany, Accpeted-November-2014 GUEST EDITOR: Thematic issue, “Anticancer Ruthenium complexes in Drug Discovery and Medicinal Chemistry” Journal “Mini Reviews in Medicinal Chemistry” Bentham Science Publications, Accepted in November-2014, Thematic issue in Press. Review Articles in Press: 1. ‘’Drug Discovery for Paediatric Chagas Disease’’ Sreekanth Thota, Carlos M. Morel, Mini Reviews in Medicinal Chemistry, July-2015 (Article in Press) 2. “Treatment and Diagnosis of Diabetes Mellitus and its Complication: Advanced Approaches”, Sreekanth Thota, Carlos M. Morel, Mini Reviews in Medicinal Chemistry, June-2015. (Article in Press) 3. ‘’Drug Discovery and Development of Antimalarial agents: Recent Advances’’, Sreekanth Thota, Yerra Rajeshwar. Current Protein and Peptide Science, July-2015.(Article in Press) 4. “Recent Advances in development of Polyphenols as Anticancer agents”, Sreekanth Thota, Mini Reviews in Medicinal Chemistry, November-2014. PUBLISHED PAPERS: International: 1. ‘’Synthesis, anticancer and cytotoxic activities of some mononuclear Ru(II) compounds’’ S.S.Karki, T. Sreekanth, YD.Satyanarayana, J.Balzarini and Ede.Clercq. Bioorganic and Medicinal Chemistry, 2007, 15 (21); 6632-6641. 2. ’’Preliminary studies on Antiinflammatory and Analgesic activities of Baliospermum Montanum’’ Baburao B, Sreekanth T, Kiran G, Rajaabhilash P, Shyamsunder A, Ravi P and Rajeshwar Y. Pharmacology Online, 2009, 1, 366-372. 3. ‘’Synthesis, characterization and antibacterial activity of some novel mononuclear Ru(II) complexes’’ Sreekanth T, Karki S.S, Baburao B. International Journal of Pharmacy and Pharmaceutical Sciences. 2009, 1(2), 62-70. 4. ‘’Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes’’ Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. Journal of Enzyme Inhibition and Medicinal Chemistry. 2010, 25 (4), 513-519. 5. ‘’Synthesis, Characterization, antitumor and cytotoxic activities of mononuclear Ru(II)complexes’’ Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. Journal of Coordination Chemistry. 2010, 63 (24), 4332-4346. 6. ‘’Synthesis, and cytotoxic activities of some mononuclear Ru(II) complexes’’ Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. Research Journal of Pharmaceutical Biological and Chemical Sciences, 2010, 1 (3), 704-713. 7. ‘’Synthesis, Characterization, and cytotoxic activity of some Ru(II) complexes’’ Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. Turkish journal of pharmaceutical sciences, 2011, 8 (3), 207-218. 8. "In-vitro Antioxidant activity of some novel synthetic mononuclear Ruthenium(II) compounds” Shyamsunder A, Sreekanth T, Rajeshwar Y, Satyavathi D. Letters in Drug Design & Discovery, 2012, 9 (4), 421-425. 9. Synthesis, spectroscopic characterization and in vitro antitumor activities of some novel mononuclear Ru(II)complexes. Sreekanth thota, Mohammad Imran, Manasa Udugula, Rajeshwar Yerra, Jan Balzarini, Erik De Clercq. Chinese Chemical Letters, 2012, 23 (4), 466-469. 10. Synthesis, spectroscopic characterization, Antineoplastic, in-vitro cytotoxic and antibacterial activities of mononuclear Ruthenium(II)complexes. Sreekanth thota, Mohammad Imran, Manasa Udugula, Rajeshwar Yerra, Jan Balzarini, Erik De Clercq. Journal of Coordination Chemistry, 2012, 65, (5) 823-839. 11. "Synthesis, antimicrobial screening and beta lactamase inhibitory activity of 3-(3-chloro-4-fluorophenylimino) indolin-2-one and 5-chloro indolin-2-one derivatives” Sreekanth T, Karki SS. Turkish journal of pharmaceutical sciences, 2012, 9(3), 353-358. 12. ‘’Novel mononuclear Ruthenium(II) Compounds in Cancer Therapy’’ Shyamsunder A, Sreekanth T, Rajeshwar Y, Krishna Prasad D, Satyavathi D. Asian Pacific Journal of Cancer Prevention. 2012, 13, 3293-3298. 13. "Microwave assisted synthesis, characterization of some new isatin and thiophene derivatives as cytotoxic and chemotherapeutic agents” Kiran Gangarapu, Sarangapani Manda, Sreekanth Thota, Rajeshwar Yerra, Subhas s Karki, Jan Balzarini, Eric De Clercq and Harukuni Tokuda. Letters in Drug Design & Discovery, 2012, 9 (4), 421-425. 14. Antimicrobial and antimalarial activity of novel synthetic mononuclear Ruthenium(II) compounds. Shyam sunder anchuri, Satyavati Dhulipala, Sreekanth Thota, Rajanarender Bongoni, Rajeshwar Yerra, Ram Narsimha Reddy. Journal of the Chinese chemical Society, 2013, 60, 153-159. 15. ‘’Synthesis, Characterization, in-vitro cytotoxic and structure activity relationships of some novel mononuclear Ru(II) complexes’’ Sreekanth T, Srujana Vallala, Mohammad Imran, Sravani Mekala, Shyam Sunder Anchuri, Subhas Somalingappa Karki, Rajeshwar Yerra, Jan Balzarini & Erik de Clercq. Journal of Coordination Chemistry. 2013, 66 (6), 1031-1045. 16. ‘’Synthesis of thiocarbohydraizde and carbohydrazide derivatives as possible biologically active agents’’ Kiran Gangarapu, Sarangapani Manda, Anvesh Jullapaly, Sreekanth Thota, Subhas Somalingappa Karki, Jan Balzarini, Erik de Clercq & Harukuni Tokuda. Medicinal Chemistry Research. 2014, 23, 1046-1056. 17. “Synthesis, characterization, in vitro cytotoxic and antioxidant activities of novel coumarin thiazolyl derivatives” Thota SREEKANTH, Nadipelly KAVITHA, Anchuri SHYAMSUNDER, Yerra RAJESHWAR, Karki SUBHAS SOMALINGAPPA, Jan BALZARINI, Erik DE CLERCQ. “International Journal of Pharmacy Education and Research’’ 2014, 1(1), 29-35. 18. “Free radical scavenging and Antifungal activity of Asparagus racemosus root extract – An in vitro study” Yerra RAJESHWAR, Thota SREEKANTH, Kanjarla NARASIMHA, Anchuri SHYAMSUNDER. “International Journal of Pharmacy Education and Research’’ 2014, 1(1), 57-60. 19. “Investigation of Phytoconstituents, TLC Profile and Antimicrobial Activity of Methanol Extract of Asparagus racemosus willd. Roots” Rajeshwar Y, Sreekanth T, Shyamsunder A, Tejaswi Divya B. “International Journal of Pharmacognosy and Phytochemical Research” 2014, 6 (1), 128-132. 20. “Synthesis, Cytostatic & Antiviral activity of some Ruthenium(II) complexes” Subhas S Karki, Sreekanth Thota. “Turkish Journal of Pharmaceutical Sciences” 2014, 11(2), 163-174. 21. “Design, synthesis, characterization, antioxidant and in vitro cytotoxic activities of novel coumarin thiazole derivatives’’ Sreekanth Thota, Kavitha Nadipelly, Anusha Shenkesi, Rajeshwar Yerra. “Medicinal Chemistry Research” 2015, 24, 1162-1169. 22. “Ru(II) complexes as cytotoxic agents: Synthesis and Structural Characterization” Sreekanth Thota, Srujana Vallala, Srinath Vudutha, Rajeshwar Yerra. World Journal of Pharmaceutical Research, 2015, 4(1), 775-782. 23. Design, Synthesis, Characterization, Cytotoxic and structure activity relationships of novel Ru(II) complexes. Sreekanth Thota, Srujana Vallala, Rajeshwar Yerra, Eliezer J. Barreiro. Chinese Chemical Letters. 2015, 26, 721-726. 24. Ru(II) complexes as Cytotoxic agents: Synthesis and structural characterization. Sreekanth Thota, Srujana Vallala, Srinath Vudutha, Rajeshwar Yerra. World Journal of Pharmaceutical Research. 2015, 4(1), 775-782. 25. Mononuclear Ru(II) compounds as novel cytotoxic agents. Shyamsunder Anchuri, Sreekanth Thota. International Journal of Pharmacy and Biological Sciences. 2015, 5(1), 138-144. 26. “Design, Synthesis, Spectroscopic characterization and in vitro antineoplastic activities of novel 5-amino-1,3,4-thiadiazole derivatives” Sreekanth Thota, Anusha Shenkesi, Yerra Rajeshwar. Medicinal Chemistry Research, 2015, Article in press. Professional Recognition: Editorial member for more than 10 international high impact journals. Reviewer and editor for more than 15 national and international journals. Guided 6 students for M.Pharm. (Pharmaceutical Chemistry). Organized several lectures (guest/extension) at the parent institution. Organized several conferences/Symposiums at the parent institution. Approved as ‘’Registered Pharmacist’’ from the Andhra Pradesh Pharmacy Council, Hyderabad,(A.P), India. Life member, Association of Pharmacy Teachers of India (APTI), India. Life member, American Chemical Society. Other Relevant Information Having an experience of 8 years in research in the fields of Pharmaceutical Chemistry, Pharmacology, Medicinal Chemistry and Phyto Chemistry. During the academic stints, have paid immense interest in participating workshops, seminars, development programmes and National and International conferences. Having 20 research publications at national and international credit, 16 abstracts and 12 presentations at national and international conferences. Reviewer for over 15 national and international journals. Having an experience in organizing workshops and seminars Approved Ph.D guide from various Universities in India. Appointed as an External examiner for B.Pharm and M.Pharm external / final examinations. Have guided several PG project works. PERSONAL DETAILS Father’s Name : T. Sambaiah Date of Birth : 19-12-1980 Marital status : Married Nationality : Indian Religion : Hindu Passport No. : Z1927242 Pharmacist Regn No. : A1040220 Driving License No. : DLFAP036178882008 Here by I am declaring that the above information is true to the best of my knowledge. Yours faithfully Sreekanth thota)
Favourite Publications: PUBLISHED BOOKS: 1. T. Sreekanth, S. S. Karki, Y. Rajeshwar. Ruthenium complexes as Anticancer agents, ISBN NO. 978-3-65912485-3. Lambert academic publications. Germany. 2012 2. D.C.Crans, T. Sreekanth, “Inorganic Cordination chemistry of Vanadium”, Comprehensive Inorganic Chemistry, Book Chapter. 3. T. Sreekanth, S. S. Karki, Y. Rajeshwar.Ruthenium compounds as Antineoplastic agents, ISBN NO. 978-3-8454-0404-2. Lambert academic publications. Germany. 2014. 4.Sreekanth Thota, “Metal Nanoparticles in Drug Discovery” Wiley-VCH Verlag GmbH & Co. KGaA, Germany, Accpeted-November-2014. GUEST EDITOR: Thematic issue, “Anticancer Ruthenium complexes in Drug Discovery and Medicinal Chemistry” Journal “Mini Reviews in Medicinal Chemistry” Bentham Science Publications, Accepted, Thematic issue in Press. Review Articles: 1. Sreekanth Thota, Carlos M. Morel, ‘’Drug Discovery for Paediatric Chagas Disease’’ Mini Reviews in Medicinal Chemistry, 2015, 15, 1. 2. Sreekanth Thota, Carlos M. Morel “Recent advances in synthetic chemistry of diabetic research”, Mini Reviews in Medicinal Chemistry, 2015, 15 (14), 1159- 1163. 3. Sreekanth Thota, Yerra Rajeshwar. ‘’Drug Discovery and Development of Antimalarial agents: Recent Advances’’, Current Protein and Peptide Science, July-2015.(Article in Press) 4. Sreekanth Thota, “Recent Advances in development of Polyphenols as Anticancer agents”, Mini Reviews in Medicinal Chemistry, Accepted. RESEARCH PUBLISHED PAPERS: International: 1.S.S.Karki, T. Sreekanth, Y.D.Satyanarayana, J.Balzarini and Ede.Clercq. ‘’Synthesis, anticancer and cytotoxic activities of some mononuclear Ru(II) compounds’’ Bioorganic and Medicinal Chemistry, 2007, 15 (21); 6632-6641. [Pubmed PMID: 17765549] Impact Factor: 2.970 2.Baburao B, Sreekanth T, Kiran G, Rajaabhilash P, Shyamsunder A, Ravi P and Rajeshwar Y. ’’Preliminary studies on Antiinflammatory and Analgesic activities of Baliospermum Montanum’’ Pharmacology Online, 2009, 1, 366-372. Impact Factor: 0.16 3. Sreekanth T, Karki S.S, Baburao B. ‘’Synthesis, characterization and antibacterial activity of some novel mononuclear Ru(II) complexes’’ International Journal of Pharmacy and Pharmaceutical Sciences. 2009, 1(2), 62-70. Impact Factor: 1.59 4. Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. ‘’Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes’’ Journal of Enzyme Inhibition and Medicinal Chemistry. 2010, 25 (4), 513-519. [Pubmed PMID: 20128638] Impact Factor: 2.33 5. Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. ‘’Synthesis, Characterization, antitumor and cytotoxic activity of mononuclear Ru(II)complexes’’ Journal of Coordination Chemistry. 2010, 63 (24), 4332-4346. Impact Factor: 2.01 6. Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. ‘’Synthesis, and cytotoxic activity of some mononuclear Ru(II) complexes’’ Research Journal of Pharmaceutical Biological and Chemical Sciences, 2010, 1 (3), 704-713. Impact Factor: 0.35 7. Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. ‘’Synthesis, Characterization, and cytotoxic activity of some Ru(II) complexes’’ Turkish journal of pharmaceutical sciences, 2011, 8 (3), 207-218. 8. Shyamsunder A, Sreekanth T, Rajeshwar Y, Satyavathi D."In-vitro Antioxidant activity of some novel synthetic mononuclear Ruthenium(II) compounds” Letters in Drug Design & Discovery, 2012, 9 (4), 421-425. Impact Factor: 0.77 9. Sreekanth thota, Mohammad Imran, Manasa Udugula, Rajeshwar Yerra, Jan Balzarini, Erik De Clercq. Synthesis, spectroscopic characterization and in vitro antitumor activities of some novel mononuclear Ru(II)complexes. Chinese Chemical Letters, 2012, 23 (4), 466-469. Impact Factor: 1.59 Sreekanth thota, Mohammad Imran, Manasa Udugula, Rajeshwar Yerra, Jan Balzarini, Erik De Clercq. Synthesis, spectroscopic characterization, Antineoplastic, in-vitro cytotoxic and antibacterial activities of mononuclear Ruthenium(II)complexes. Journal of Coordination Chemistry, 2012, 65, (5) 823-839. Impact Factor: 2.01 10. Sreekanth T, Karki S.S."Synthesis, antimicrobial screening and beta lactamase inhibitory activity of 3-(3-chloro-4-fluorophenylimino) indolin-2-one and 5-chloro indolin-2-one derivatives” Turkish journal of pharmaceutical sciences, 2012, 9(3), 353-358. 11. Shyamsunder A, Sreekanth T, Rajeshwar Y, Krishna Prasad D, Satyavathi D. ‘’Novel mononuclear Ruthenium(II) Compounds in Cancer Therapy’’ Asian Pacific Journal of Cancer Prevention. 2012, 13, 3293-3298. [Pubmed PMID: 22994750] Impact Factor: 2.33 12. Kiran Gangarapu, Sarangapani Manda, Sreekanth Thota, Rajeshwar Yerra, Subhas s Karki, Jan Balzarini, Eric De Clercq and Harukuni Tokuda. "Microwave assisted synthesis, characterization of some new isatin and thiophene derivatives as cytotoxic and chemotherapeutic agents” Letters in Drug Design & Discovery, 2012, 9 (4), 421-425. Impact Factor: 0.77 13.Shyam sunder anchuri, Satyavati Dhulipala, Sreekanth Thota, Rajanarender Bongoni, Rajeshwar Yerra, Ram Narsimha Reddy. Antimicrobial and antimalarial activity of novel synthetic mononuclear Ruthenium(II) compounds. Journal of the Chinese chemical Society, 2013, 60, 153-159. Impact Factor: 0.65 14. Sreekanth T, Srujana Vallala, Mohammad Imran, Sravani Mekala, Shyam Sunder Anchuri, Subhas Somalingappa Karki, Rajeshwar Yerra, Jan Balzarini & Erik de Clercq. ‘’Synthesis, Characterization, in-vitro cytotoxic and structure activity relationships of some novel mononuclear Ru(II) complexes’’ Journal of Coordination Chemistry. 2013, 66 (6), 1031-1045. Impact Factor: 2.01 Shyam sunder anchuri, Satyavati Dhulipala, Sreekanth Thota, Rajeshwar Yerra, Jan Balzarini & Erik de Clercq. Antinociceptive and antitumor activity of novel synthetic mononuclear Ruthenium (II) compounds. Journal of Research in Medical Sciences, 2013, 18, 215-221. [Pubmed PMID: 23930118] 15. Kiran Gangarapu, Sarangapani Manda, Anvesh Jullapaly, Sreekanth Thota, Subhas Somalingappa Karki, Jan Balzarini, Erik de Clercq & Harukuni Tokuda. ‘’Synthesis of thiocarbohydraizde and carbohydrazide derivatives as possible biologically active agents’’ Medicinal Chemistry Research, 2014, 23, 1046-1056. Impact Factor: 1.40 16. Thota SREEKANTH, Nadipelly KAVITHA, Anchuri SHYAMSUNDER, Yerra RAJESHWAR, Karki SUBHAS SOMALINGAPPA, Jan BALZARINI, Erik DE CLERCQ. “Synthesis, characterization, in vitro cytotoxic and antioxidant activities of novel coumarin thiazolyl derivatives” “International Journal of Pharmacy Education and Research’’ 2014, 1(1), 29-35. 17. Yerra RAJESHWAR, Thota SREEKANTH, Kanjarla NARASIMHA, Anchuri SHYAMSUNDER. “Free radical scavenging and Antifungal activity of Asparagus racemosus root extract – An in vitro study” “International Journal of Pharmacy Education and Research’’ 2014, 1(1), 57-60. 18. Yerra RAJESHWAR, Thota SREEKANTH “Investigation of Phytoconstituents, TLC Profile and Antimicrobial Activity of Methanol Extract of Asparagus racemosus willd. Roots” “International Journal of Pharmacognosy and Phytochemical Research” 2014, 6 (1), 128-132. 19. Subhas S Karki, Sreekanth Thota. “Synthesis, Cytostatic & Antiviral activity of some Ruthenium(II) complexes” “Turkish Journal of Pharmaceutical Sciences” 2014, 11(2), 163-174. 20. Sreekanth Thota, Kavitha Nadipelly, Anusha Shenkesi, Rajeshwar Yerra. “Design, synthesis, characterization, antioxidant and in vitro cytotoxic activities of novel coumarin thiazole derivatives’’ “Medicinal Chemistry Research” 2015, 24, 1162- 1169. Impact Factor: 1.40 21. Sreekanth Thota, Srujana Vallala, Srinath Vudutha, Rajeshwar Yerra. “Ru(II) complexes as cytotoxic agents: Synthesis and Structural Characterization” World Journal of Pharmaceutical Research, 2015, 4(1), 775-782. Impact Factor: 5.99 22.Sreekanth Thota, Srujana Vallala, Rajeshwar Yerra, Eliezer J. Barreiro. Design, Synthesis, Characterization, Cytotoxic and structure activity relationships of novel Ru(II) complexes. Chinese Chemical Letters. 2015, 26, 721-726. Impact Factor: 1.59 23.Shyamsunder Anchuri, Sreekanth Thota. Mononuclear Ru(II) compounds as novel cytotoxic agents. International Journal of Pharmacy and Biological Sciences. 2015, 5(1), 138-144. Impact Factor: 0.56 24. Sreekanth Thota, Anusha Shenkesi, Yerra Rajeshwar. “Design, Synthesis, Spectroscopic characterization and in vitro antineoplastic activities of novel 5- amino-1,3,4-thiadiazole derivatives” Medicinal Chemistry Research, 2015, Article in press. Impact Factor: 1.40 25.Sreekanth Thota, Srujana Vallala, Rajeshwar Yerra, Daniel Alencar Rodrigues, Nulgumnalli Manjunathaiah Raghavendra, Eliezer J. Barreiro. Synthesis,Characterization, DNA binding, DNA cleavage, protein binding and cytotoxic Activities of novel Ru(II) complexes. International Journal of Biological Macromolecule. Accepted September-2015, Article in Press.[Pubmed PMID: 26424207] Impact Factor: 3.016
Work: 1. Hands on experience in the synthesizing the Inorganic (Ruthenium Complexes) and Heterocyclic compounds for possible biological activity. 2. Anticancer activity 3. QSAR study 4. In vitro studies including DPPH, hydroxyl radical, reducing power, total phenolic content, super oxide, hydroperoxide, nitric oxide radicals, lipid peroxidation, etc., and in vivo studies including TBARS, reduced GSH, CAT, SOD, total protein, etc. 5. Working with animal models including mice and rats for various pharmacological studies. 6. Hands on experience with analytical tools including Colorimeter, UV-Vis Spectrophotometer, TLC technique, and HPLC.
Affiliations: PRESENT AFFILIATION: Dr. SREEKANTH THOTA M.Pharmacy., Ph.D. PDF (USA) Visiting Professor, CAPES-Fiocruz/CDTS Centre for Technological Development in Health, Oswaldo Cruz Foundation (Fiocruz) Building "Expansão", 8th floor - room 814 Av. Brasil 4036 - Manguinhos Rio de Janeiro, RJ 21040-361 Brazil. sthota@cdts.fiocruz.br thota@colostate.edu stsreekanththota@gmail.com Work +55-21-3882-9234 Cell +55-21-979-555-328 Fax +55-21-2290-0494 PAST AFFILIATION: COLORADO STATE UNIVERSITY, Department of Chemistry, Colorado State University Address Fort Collins, Colorado 80523-1872.
Contact: Dr. SREEKANTH THOTA M.Pharmacy., Ph.D. PDF (USA) Visiting Professor, CAPES-Fiocruz/CDTS Centre for Technological Development in Health, Oswaldo Cruz Foundation (Fiocruz) Building "Expansão", 8th floor - room 814 Av. Brasil 4036 - Manguinhos Rio de Janeiro, RJ 21040-361 Brazil. sthota@cdts.fiocruz.br stsreekanththota@gmail.com Work +55-21-3882-9234 Cell +55-21-979-555-328 Fax +55-21-2290-0494
Biographical: Dr. SREEKANTH THOTA M.Pharmacy., Ph.D. PDF (USA) Visiting Professor, National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN) Centre for Technological Development in Health, Oswaldo Cruz Foundation (Fiocruz) Building "Expansão", 8th floor - room 814 Av. Brasil 4036 - Manguinhos Rio de Janeiro, RJ 21040-361 Brazil. sthota@cdts.fiocruz.br thota@colostate.edu stsreekanththota@gmail.com Work +55-21-3882-9234 Cell +55-21-979555328 Fax +55-21-2290-0494 Permanent address India: # 17-4-100 Kareemabad, Warangal-506002 Andhra Pradesh INDIA. EDUCATION AND RESEARCH TRAINING: • 2013 Worked as a Postdoctoral Research Scholar at Colorado State University, Fortcollins, Colorado-80521, USA. • 2006-2011 Ph.D at Jawaharlal Nehru Technological University Hyderabad, Research & Development cell, Kukatpally, Hyderabad-500085 (India). • 2004-2006, M.Pharm, Pharmaceutical Chemistry, K.L.E.S’s College of Pharmacy, Bangalore, Rajiv Gandhi University of Health sciences (India). • 1999-2003, B.Pharm, Talla Padmavathi College of Pharmacy, Kakatiya University, Warangal, (India). Professional Teaching Experience: 2006 to till date 1. Serving as a Full time Visiting Scientist in National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Centre for Technological Development in Health, Fiocruz, Rio de Janeiro, Brasil from September 2014 to till date. 2. Served as Full time Associate Professor, Head of the Department for Pharmaceutical Chemistry at S. R. College of Pharmacy, Ananthasagar, Warangal, India. (November-2013 to August-2014 ) 3. Worked as a Postdoctoral Research Scholar in Colorado State University, Department of Chemistry and Molecular Sciences. (2013) 4. Served as Full time Associate Professor, Head of the Department for Pharmaceutical Chemistry at S. R. College of Pharmacy, Ananthasagar, Warangal, India. (April-2011 to 2013) 5. Served as Assistant. Professor, at S .R. College of Pharmacy, Ananthasagar, Warangal, India. (August-2008 to July-2010) 6. Served as a Lecturer/Assistant Professor, at Blue Birds College of Pharmacy, Bheemaram Warangal. (June-2006 to July 2008) Research projects working/ worked 1. Cu-Peptide complexes triggering effect on the protein aggregation. 2. Design, Synthesis, Characterization, Anticancer and Quantitaive Structure Activity relationship of some novel 1,3,4-thiadiazole derivatives. 3. Synthesis, characterization and QSAR studies of novel pyrazole derivatives. 4. Synthesis, Spectroscopic Characterization and Antitumor activities of certain novel mononuclear Ru(II) complexes. 5. Design, Synthesis, Characerization, antiviral and antimicrobial activities of novel imidazo (2, 1-b)-Thiadiazole derivatives. 6. Synthesis, Spectroscopic Characterization and Antioxidant and Antimicrobial activities of novel quinazoline derivatives. Collaborative Research: 1. INCT-IDN, National Institute of Science and Technology of innovation in neglected diseases. Rio de Janeiro, Brazil. 2. National Institute of Health, Bethesda, USA. 3. Prof. Eliezer J. Barreiro, LASSBio, UFRJ, Cidade Universitaria, Rio de Janeiro, Brazil. 4. Prof. Dr. Erick De Clercq, Rega Institute for Medical Research, minderbroedersstraat, 10, B-3000, Leuven, Belgium. 5. Prof. Debbie C Crans, Department of Chemistry, Colorado State University, USA. 6. Dept. of Engineering Physics, MS Ramaiah College of Engineering, Bangalore. 4. Dr. Sathees Raghavan, Assistant Professor, Biochemistry Dept. Indian Institute of Science, Bangalore. AWARDS AND FELLOWSHIPS « Receipient of Visiting Professor fellowship from National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Centre for Technological Development in Health, Fiocruz, Rio de Janeiro, Brasil. (2014-2018) « Postdoctoral fellowship from Colorado State University, Colorado, Fortcollins, USA. (2013) « Recepient of “RESEARCH PROMOTION SCHEME” AICTE Project fellowship, Principal Investigator, India. « DST-SERC Young Scientist Award, INDIA. « Associate Editor for International Journals. Reviewer for the following journals: 1. American Chemical Society Journals 2. Journal of molecular structure 3. Journal of Microbiology and Antimicrobials 4. European Journal of Medicinal Chemistry 5. Journal of Coordinaion Chemistry 6. Asian Journal of Pharmaceutical and Biological Research 7. Several Indian journals etc… Presentation of Papers at Conferences / Seminars: 1. Presented poster paper on “Synthesis and in-vitro anticancer activity of some novel mononuclear Ru(II) complexes” T. Sreekanth, Subhas S Karki, at 2nd International conference on Drug Design and Process Research” held at KLES College of Pharmacy, Belgaum, Karnataka, India, 10-12, February 2006. 2. Presented poster paper on “Synthesis, characterization and pharmacological activities of some novel mononuclear Ru(II) complexes” T. Sreekanth, Subhas S Karki, at Emerging trends in pharmaceutical sciences, AICTE sponsored program, held at M.N.R.College of pharmacy, Sangareddy, HYDERABAD, India, 27-28, Febrauary 2009. 3. presented oral paper on “Synthesis, characterisation and In-vitro cytotoxicactivities of some Ru(II) complexes” T. Sreekanth, Subhas S Karki, at 14th Annual Green Chemistry & Engineering Conference, held at Capital Hilton, 1001 16th St. NW, Washington, DC 20036. U.S.A. june 21-23, 2010. 4. Synthesis, spectral characterization antioxidant and antimicrobial activities of some novel mononuclear Ru(II)complexes. Mohammad Imran, Sreekanth Thota, B.Rajanarender, Y.Rajeshwar. AAPS, NIPER, September 3rd -4th 2011. 5. Synthesis, spectroscopic characterization, in vitro antitumor and antibacterial activity of Ru(II) complexes. T. Sreekanth, Md. Imran, U. Manasa, Y. Rajeshwar, Subhas S Karki, Jan Balzarini & Erik De Clercq. National Symposium on “Recent Trends in Pharmacy Education and Industry” 11th February, 2012. 6. An overview of Microwave Assisted Green Synthesis, M. Sravani, A. Naresh, A. Navitha, T.Sreekanth & Y. Rajeshwar. National Symposium on “Recent Trends in Pharmacy Education and Industry” 11th February, 2012. 7. In vitro Antioxidant activity of some novel synthetic mononuclear Ru(II) compounds. A. Shyam Sunder, T. Sreekanth, Y. Rajeshwar & D. Satyavathi. National Symposium on “Recent Trends in Pharmacy Education and Industry” 8. Synthesis, spectroscopic characterization and invitro cytotoxic activities of novel mononuclear Ru(II)complexes. T. Sreekanth, Md. Imran, Jan Balzarini, Erik De Clercq & Y. Rajeshwar. 63rd IPC-Bangalore. 9. Synthesis, spectroscopic characterization and in vitro cytotoxic activities of mononuclear Ru(II) complexes. T. Sreekanth, Md. Imran, U. Manasa, Y. Rajeshwar, Subhas S Karki, Jan Balzarini & Erik De Clercq. American Chemical Society, Division of Medicinal Chemistry, 243rd National Meeting & Exposition. March 25-29, 2012, sandiego, california. Accepted paper and published in online abstract book. 10. Synthesis, characterization antioxidant & antimicrobial activities of some novel Pyrazoline derivatives. T. Sreekanth, Md. Imran, U. Manasa, Y. Rajeshwar, Subhas S Karki, Jan Balzarini & Erik De Clercq. American Chemical Society, Division of Medicinal Chemistry, 243rd National Meeting & Exposition. March 25-29, 2012, sandiego, california. Published in online abstract book. 11. Design, Synthesis, characterization and in-vitro anticancer activitiy of novel Ru(II) complexes. Sreekanth Thota, Sravani Mekala, Anusha Shenkesi, Rajeshwar Yerra, Subhas S Karki, Jan Balzarini & Erik De Clercq. IPC-2012. Accepted Paper. 12. Design, Synthesis, and biological evaluation of a novel 1,3,4-thiadiazole derivatives as anti-inflammatory and anti microbial agents. Sreekanth Thota, Sravani Mekala, Anusha Shenkesi, Rajeshwar Yerra, Subhas S Karki, Jan Balzarini & Erik De Clercq. IPC-2012. Accepted Paper. 13. Antinociceptive activity of novel synthetic mononuclear Ruthenium(II) compounds. Shyam Sunder Anchuri, Sreekanth Thota, Rajeshwar Yerra, Satyavathi Dhulipala and P. Sowmya. 14. Development of novel potential Antineoplastic agents. Sreekanth Thota, Rajeshwar Yerra, Debbie C Crans. “Translational Science at fiocruz, Building international Collaborations” Brazil, Riode Janerio, December 2-6th, 2013. 15. Synthesis, Characetrization and Invitro cytotxic activity of some Ru(II) complexes. Srujana Vallala, Rajeshwar Yerra, Sreekanth Thota, Jan Balzarini, Erik De Clercq. International conference on Drugs for the Future: Infectious Diseases. Antimicrobial Drug Discovery: Challenges and Perspectives. NIPER, Hyderabad, March 27-28th, 2014. 16. Design, Synthesis and spectroscopic characterization of novel 1,3,4-thiadiazole derivatives as Antimicrobial agents. Sreekanth Thota, Rajeshwar Yerra. International conference on Drugs for the Future: Infectious Diseases. Antimicrobial Drug Discovery: Challenges and Perspectives. NIPER, Hyderabad, March 27-28th, 2014. 17. “New Strategies for Research and Development”. Sreekanth Thota, Carlos M. Morel. 9th European Congress on Tropical Medicine and International Health which will take place in Basel, Switzerland from 6 -10 September 2015. Accepted Poster Presentation. PUBLISHED BOOKS: 1. Ruthenium complexes as Anticancer agents, T. Sreekanth, S. S. Karki, Y. Rajeshwar. ISBN NO. 978-3-65912485-3. Lambert academic publications. Germany. 2012 2. “Inorganic Cordination chemistry of Vanadium”, D.C.Crans, T. Sreekanth, Comprehensive Inorganic Chemistry, Book Chapter, accepted in September-2014. 3. Ruthenium compounds as Antineoplastic agents, T. Sreekanth, S. S. Karki, Y. Rajeshwar. . ISBN NO. 978-3-8454-0404-2. Lambert academic publications. Germany. 2014. 4. “Metal Nanoparticles in Drug Discovery” Sreekanth Thota, Wiley-VCH Verlag GmbH & Co. KGaA, Germany, Accpeted-November-2014 GUEST EDITOR: Thematic issue, “Anticancer Ruthenium complexes in Drug Discovery and Medicinal Chemistry” Journal “Mini Reviews in Medicinal Chemistry” Bentham Science Publications, Accepted in November-2014, Thematic issue in Press. Review Articles in Press: 1. ‘’Drug Discovery for Paediatric Chagas Disease’’ Sreekanth Thota, Carlos M. Morel, Mini Reviews in Medicinal Chemistry, July-2015 (Article in Press) 2. “Treatment and Diagnosis of Diabetes Mellitus and its Complication: Advanced Approaches”, Sreekanth Thota, Carlos M. Morel, Mini Reviews in Medicinal Chemistry, June-2015. (Article in Press) 3. ‘’Drug Discovery and Development of Antimalarial agents: Recent Advances’’, Sreekanth Thota, Yerra Rajeshwar. Current Protein and Peptide Science, July-2015.(Article in Press) 4. “Recent Advances in development of Polyphenols as Anticancer agents”, Sreekanth Thota, Mini Reviews in Medicinal Chemistry, November-2014. PUBLISHED PAPERS: International: 1. ‘’Synthesis, anticancer and cytotoxic activities of some mononuclear Ru(II) compounds’’ S.S.Karki, T. Sreekanth, YD.Satyanarayana, J.Balzarini and Ede.Clercq. Bioorganic and Medicinal Chemistry, 2007, 15 (21); 6632-6641. 2. ’’Preliminary studies on Antiinflammatory and Analgesic activities of Baliospermum Montanum’’ Baburao B, Sreekanth T, Kiran G, Rajaabhilash P, Shyamsunder A, Ravi P and Rajeshwar Y. Pharmacology Online, 2009, 1, 366-372. 3. ‘’Synthesis, characterization and antibacterial activity of some novel mononuclear Ru(II) complexes’’ Sreekanth T, Karki S.S, Baburao B. International Journal of Pharmacy and Pharmaceutical Sciences. 2009, 1(2), 62-70. 4. ‘’Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes’’ Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. Journal of Enzyme Inhibition and Medicinal Chemistry. 2010, 25 (4), 513-519. 5. ‘’Synthesis, Characterization, antitumor and cytotoxic activities of mononuclear Ru(II)complexes’’ Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. Journal of Coordination Chemistry. 2010, 63 (24), 4332-4346. 6. ‘’Synthesis, and cytotoxic activities of some mononuclear Ru(II) complexes’’ Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. Research Journal of Pharmaceutical Biological and Chemical Sciences, 2010, 1 (3), 704-713. 7. ‘’Synthesis, Characterization, and cytotoxic activity of some Ru(II) complexes’’ Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. Turkish journal of pharmaceutical sciences, 2011, 8 (3), 207-218. 8. "In-vitro Antioxidant activity of some novel synthetic mononuclear Ruthenium(II) compounds” Shyamsunder A, Sreekanth T, Rajeshwar Y, Satyavathi D. Letters in Drug Design & Discovery, 2012, 9 (4), 421-425. 9. Synthesis, spectroscopic characterization and in vitro antitumor activities of some novel mononuclear Ru(II)complexes. Sreekanth thota, Mohammad Imran, Manasa Udugula, Rajeshwar Yerra, Jan Balzarini, Erik De Clercq. Chinese Chemical Letters, 2012, 23 (4), 466-469. 10. Synthesis, spectroscopic characterization, Antineoplastic, in-vitro cytotoxic and antibacterial activities of mononuclear Ruthenium(II)complexes. Sreekanth thota, Mohammad Imran, Manasa Udugula, Rajeshwar Yerra, Jan Balzarini, Erik De Clercq. Journal of Coordination Chemistry, 2012, 65, (5) 823-839. 11. "Synthesis, antimicrobial screening and beta lactamase inhibitory activity of 3-(3-chloro-4-fluorophenylimino) indolin-2-one and 5-chloro indolin-2-one derivatives” Sreekanth T, Karki SS. Turkish journal of pharmaceutical sciences, 2012, 9(3), 353-358. 12. ‘’Novel mononuclear Ruthenium(II) Compounds in Cancer Therapy’’ Shyamsunder A, Sreekanth T, Rajeshwar Y, Krishna Prasad D, Satyavathi D. Asian Pacific Journal of Cancer Prevention. 2012, 13, 3293-3298. 13. "Microwave assisted synthesis, characterization of some new isatin and thiophene derivatives as cytotoxic and chemotherapeutic agents” Kiran Gangarapu, Sarangapani Manda, Sreekanth Thota, Rajeshwar Yerra, Subhas s Karki, Jan Balzarini, Eric De Clercq and Harukuni Tokuda. Letters in Drug Design & Discovery, 2012, 9 (4), 421-425. 14. Antimicrobial and antimalarial activity of novel synthetic mononuclear Ruthenium(II) compounds. Shyam sunder anchuri, Satyavati Dhulipala, Sreekanth Thota, Rajanarender Bongoni, Rajeshwar Yerra, Ram Narsimha Reddy. Journal of the Chinese chemical Society, 2013, 60, 153-159. 15. ‘’Synthesis, Characterization, in-vitro cytotoxic and structure activity relationships of some novel mononuclear Ru(II) complexes’’ Sreekanth T, Srujana Vallala, Mohammad Imran, Sravani Mekala, Shyam Sunder Anchuri, Subhas Somalingappa Karki, Rajeshwar Yerra, Jan Balzarini & Erik de Clercq. Journal of Coordination Chemistry. 2013, 66 (6), 1031-1045. 16. ‘’Synthesis of thiocarbohydraizde and carbohydrazide derivatives as possible biologically active agents’’ Kiran Gangarapu, Sarangapani Manda, Anvesh Jullapaly, Sreekanth Thota, Subhas Somalingappa Karki, Jan Balzarini, Erik de Clercq & Harukuni Tokuda. Medicinal Chemistry Research. 2014, 23, 1046-1056. 17. “Synthesis, characterization, in vitro cytotoxic and antioxidant activities of novel coumarin thiazolyl derivatives” Thota SREEKANTH, Nadipelly KAVITHA, Anchuri SHYAMSUNDER, Yerra RAJESHWAR, Karki SUBHAS SOMALINGAPPA, Jan BALZARINI, Erik DE CLERCQ. “International Journal of Pharmacy Education and Research’’ 2014, 1(1), 29-35. 18. “Free radical scavenging and Antifungal activity of Asparagus racemosus root extract – An in vitro study” Yerra RAJESHWAR, Thota SREEKANTH, Kanjarla NARASIMHA, Anchuri SHYAMSUNDER. “International Journal of Pharmacy Education and Research’’ 2014, 1(1), 57-60. 19. “Investigation of Phytoconstituents, TLC Profile and Antimicrobial Activity of Methanol Extract of Asparagus racemosus willd. Roots” Rajeshwar Y, Sreekanth T, Shyamsunder A, Tejaswi Divya B. “International Journal of Pharmacognosy and Phytochemical Research” 2014, 6 (1), 128-132. 20. “Synthesis, Cytostatic & Antiviral activity of some Ruthenium(II) complexes” Subhas S Karki, Sreekanth Thota. “Turkish Journal of Pharmaceutical Sciences” 2014, 11(2), 163-174. 21. “Design, synthesis, characterization, antioxidant and in vitro cytotoxic activities of novel coumarin thiazole derivatives’’ Sreekanth Thota, Kavitha Nadipelly, Anusha Shenkesi, Rajeshwar Yerra. “Medicinal Chemistry Research” 2015, 24, 1162-1169. 22. “Ru(II) complexes as cytotoxic agents: Synthesis and Structural Characterization” Sreekanth Thota, Srujana Vallala, Srinath Vudutha, Rajeshwar Yerra. World Journal of Pharmaceutical Research, 2015, 4(1), 775-782. 23. Design, Synthesis, Characterization, Cytotoxic and structure activity relationships of novel Ru(II) complexes. Sreekanth Thota, Srujana Vallala, Rajeshwar Yerra, Eliezer J. Barreiro. Chinese Chemical Letters. 2015, 26, 721-726. 24. Ru(II) complexes as Cytotoxic agents: Synthesis and structural characterization. Sreekanth Thota, Srujana Vallala, Srinath Vudutha, Rajeshwar Yerra. World Journal of Pharmaceutical Research. 2015, 4(1), 775-782. 25. Mononuclear Ru(II) compounds as novel cytotoxic agents. Shyamsunder Anchuri, Sreekanth Thota. International Journal of Pharmacy and Biological Sciences. 2015, 5(1), 138-144. 26. “Design, Synthesis, Spectroscopic characterization and in vitro antineoplastic activities of novel 5-amino-1,3,4-thiadiazole derivatives” Sreekanth Thota, Anusha Shenkesi, Yerra Rajeshwar. Medicinal Chemistry Research, 2015, Article in press. Professional Recognition: Editorial member for more than 10 international high impact journals. Reviewer and editor for more than 15 national and international journals. Guided 6 students for M.Pharm. (Pharmaceutical Chemistry). Organized several lectures (guest/extension) at the parent institution. Organized several conferences/Symposiums at the parent institution. Approved as ‘’Registered Pharmacist’’ from the Andhra Pradesh Pharmacy Council, Hyderabad,(A.P), India. Life member, Association of Pharmacy Teachers of India (APTI), India. Life member, American Chemical Society. Other Relevant Information Having an experience of 8 years in research in the fields of Pharmaceutical Chemistry, Pharmacology, Medicinal Chemistry and Phyto Chemistry. During the academic stints, have paid immense interest in participating workshops, seminars, development programmes and National and International conferences. Having 20 research publications at national and international credit, 16 abstracts and 12 presentations at national and international conferences. Reviewer for over 15 national and international journals. Having an experience in organizing workshops and seminars Approved Ph.D guide from various Universities in India. Appointed as an External examiner for B.Pharm and M.Pharm external / final examinations. Have guided several PG project works. PERSONAL DETAILS Father’s Name : T. Sambaiah Date of Birth : 19-12-1980 Marital status : Married Nationality : Indian Religion : Hindu Passport No. : Z1927242 Pharmacist Regn No. : A1040220 Driving License No. : DLFAP036178882008 Here by I am declaring that the above information is true to the best of my knowledge. Yours faithfully Sreekanth thota)
Favourite Publications: PUBLISHED BOOKS: 1. T. Sreekanth, S. S. Karki, Y. Rajeshwar. Ruthenium complexes as Anticancer agents, ISBN NO. 978-3-65912485-3. Lambert academic publications. Germany. 2012 2. D.C.Crans, T. Sreekanth, “Inorganic Cordination chemistry of Vanadium”, Comprehensive Inorganic Chemistry, Book Chapter. 3. T. Sreekanth, S. S. Karki, Y. Rajeshwar.Ruthenium compounds as Antineoplastic agents, ISBN NO. 978-3-8454-0404-2. Lambert academic publications. Germany. 2014. 4.Sreekanth Thota, “Metal Nanoparticles in Drug Discovery” Wiley-VCH Verlag GmbH & Co. KGaA, Germany, Accpeted-November-2014. GUEST EDITOR: Thematic issue, “Anticancer Ruthenium complexes in Drug Discovery and Medicinal Chemistry” Journal “Mini Reviews in Medicinal Chemistry” Bentham Science Publications, Accepted, Thematic issue in Press. Review Articles: 1. Sreekanth Thota, Carlos M. Morel, ‘’Drug Discovery for Paediatric Chagas Disease’’ Mini Reviews in Medicinal Chemistry, 2015, 15, 1. 2. Sreekanth Thota, Carlos M. Morel “Recent advances in synthetic chemistry of diabetic research”, Mini Reviews in Medicinal Chemistry, 2015, 15 (14), 1159- 1163. 3. Sreekanth Thota, Yerra Rajeshwar. ‘’Drug Discovery and Development of Antimalarial agents: Recent Advances’’, Current Protein and Peptide Science, July-2015.(Article in Press) 4. Sreekanth Thota, “Recent Advances in development of Polyphenols as Anticancer agents”, Mini Reviews in Medicinal Chemistry, Accepted. RESEARCH PUBLISHED PAPERS: International: 1.S.S.Karki, T. Sreekanth, Y.D.Satyanarayana, J.Balzarini and Ede.Clercq. ‘’Synthesis, anticancer and cytotoxic activities of some mononuclear Ru(II) compounds’’ Bioorganic and Medicinal Chemistry, 2007, 15 (21); 6632-6641. [Pubmed PMID: 17765549] Impact Factor: 2.970 2.Baburao B, Sreekanth T, Kiran G, Rajaabhilash P, Shyamsunder A, Ravi P and Rajeshwar Y. ’’Preliminary studies on Antiinflammatory and Analgesic activities of Baliospermum Montanum’’ Pharmacology Online, 2009, 1, 366-372. Impact Factor: 0.16 3. Sreekanth T, Karki S.S, Baburao B. ‘’Synthesis, characterization and antibacterial activity of some novel mononuclear Ru(II) complexes’’ International Journal of Pharmacy and Pharmaceutical Sciences. 2009, 1(2), 62-70. Impact Factor: 1.59 4. Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. ‘’Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes’’ Journal of Enzyme Inhibition and Medicinal Chemistry. 2010, 25 (4), 513-519. [Pubmed PMID: 20128638] Impact Factor: 2.33 5. Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. ‘’Synthesis, Characterization, antitumor and cytotoxic activity of mononuclear Ru(II)complexes’’ Journal of Coordination Chemistry. 2010, 63 (24), 4332-4346. Impact Factor: 2.01 6. Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. ‘’Synthesis, and cytotoxic activity of some mononuclear Ru(II) complexes’’ Research Journal of Pharmaceutical Biological and Chemical Sciences, 2010, 1 (3), 704-713. Impact Factor: 0.35 7. Sreekanth T, Karki SS, Jayaveera K.N, Balzarini J, Clercq Ede. ‘’Synthesis, Characterization, and cytotoxic activity of some Ru(II) complexes’’ Turkish journal of pharmaceutical sciences, 2011, 8 (3), 207-218. 8. Shyamsunder A, Sreekanth T, Rajeshwar Y, Satyavathi D."In-vitro Antioxidant activity of some novel synthetic mononuclear Ruthenium(II) compounds” Letters in Drug Design & Discovery, 2012, 9 (4), 421-425. Impact Factor: 0.77 9. Sreekanth thota, Mohammad Imran, Manasa Udugula, Rajeshwar Yerra, Jan Balzarini, Erik De Clercq. Synthesis, spectroscopic characterization and in vitro antitumor activities of some novel mononuclear Ru(II)complexes. Chinese Chemical Letters, 2012, 23 (4), 466-469. Impact Factor: 1.59 Sreekanth thota, Mohammad Imran, Manasa Udugula, Rajeshwar Yerra, Jan Balzarini, Erik De Clercq. Synthesis, spectroscopic characterization, Antineoplastic, in-vitro cytotoxic and antibacterial activities of mononuclear Ruthenium(II)complexes. Journal of Coordination Chemistry, 2012, 65, (5) 823-839. Impact Factor: 2.01 10. Sreekanth T, Karki S.S."Synthesis, antimicrobial screening and beta lactamase inhibitory activity of 3-(3-chloro-4-fluorophenylimino) indolin-2-one and 5-chloro indolin-2-one derivatives” Turkish journal of pharmaceutical sciences, 2012, 9(3), 353-358. 11. Shyamsunder A, Sreekanth T, Rajeshwar Y, Krishna Prasad D, Satyavathi D. ‘’Novel mononuclear Ruthenium(II) Compounds in Cancer Therapy’’ Asian Pacific Journal of Cancer Prevention. 2012, 13, 3293-3298. [Pubmed PMID: 22994750] Impact Factor: 2.33 12. Kiran Gangarapu, Sarangapani Manda, Sreekanth Thota, Rajeshwar Yerra, Subhas s Karki, Jan Balzarini, Eric De Clercq and Harukuni Tokuda. "Microwave assisted synthesis, characterization of some new isatin and thiophene derivatives as cytotoxic and chemotherapeutic agents” Letters in Drug Design & Discovery, 2012, 9 (4), 421-425. Impact Factor: 0.77 13.Shyam sunder anchuri, Satyavati Dhulipala, Sreekanth Thota, Rajanarender Bongoni, Rajeshwar Yerra, Ram Narsimha Reddy. Antimicrobial and antimalarial activity of novel synthetic mononuclear Ruthenium(II) compounds. Journal of the Chinese chemical Society, 2013, 60, 153-159. Impact Factor: 0.65 14. Sreekanth T, Srujana Vallala, Mohammad Imran, Sravani Mekala, Shyam Sunder Anchuri, Subhas Somalingappa Karki, Rajeshwar Yerra, Jan Balzarini & Erik de Clercq. ‘’Synthesis, Characterization, in-vitro cytotoxic and structure activity relationships of some novel mononuclear Ru(II) complexes’’ Journal of Coordination Chemistry. 2013, 66 (6), 1031-1045. Impact Factor: 2.01 Shyam sunder anchuri, Satyavati Dhulipala, Sreekanth Thota, Rajeshwar Yerra, Jan Balzarini & Erik de Clercq. Antinociceptive and antitumor activity of novel synthetic mononuclear Ruthenium (II) compounds. Journal of Research in Medical Sciences, 2013, 18, 215-221. [Pubmed PMID: 23930118] 15. Kiran Gangarapu, Sarangapani Manda, Anvesh Jullapaly, Sreekanth Thota, Subhas Somalingappa Karki, Jan Balzarini, Erik de Clercq & Harukuni Tokuda. ‘’Synthesis of thiocarbohydraizde and carbohydrazide derivatives as possible biologically active agents’’ Medicinal Chemistry Research, 2014, 23, 1046-1056. Impact Factor: 1.40 16. Thota SREEKANTH, Nadipelly KAVITHA, Anchuri SHYAMSUNDER, Yerra RAJESHWAR, Karki SUBHAS SOMALINGAPPA, Jan BALZARINI, Erik DE CLERCQ. “Synthesis, characterization, in vitro cytotoxic and antioxidant activities of novel coumarin thiazolyl derivatives” “International Journal of Pharmacy Education and Research’’ 2014, 1(1), 29-35. 17. Yerra RAJESHWAR, Thota SREEKANTH, Kanjarla NARASIMHA, Anchuri SHYAMSUNDER. “Free radical scavenging and Antifungal activity of Asparagus racemosus root extract – An in vitro study” “International Journal of Pharmacy Education and Research’’ 2014, 1(1), 57-60. 18. Yerra RAJESHWAR, Thota SREEKANTH “Investigation of Phytoconstituents, TLC Profile and Antimicrobial Activity of Methanol Extract of Asparagus racemosus willd. Roots” “International Journal of Pharmacognosy and Phytochemical Research” 2014, 6 (1), 128-132. 19. Subhas S Karki, Sreekanth Thota. “Synthesis, Cytostatic & Antiviral activity of some Ruthenium(II) complexes” “Turkish Journal of Pharmaceutical Sciences” 2014, 11(2), 163-174. 20. Sreekanth Thota, Kavitha Nadipelly, Anusha Shenkesi, Rajeshwar Yerra. “Design, synthesis, characterization, antioxidant and in vitro cytotoxic activities of novel coumarin thiazole derivatives’’ “Medicinal Chemistry Research” 2015, 24, 1162- 1169. Impact Factor: 1.40 21. Sreekanth Thota, Srujana Vallala, Srinath Vudutha, Rajeshwar Yerra. “Ru(II) complexes as cytotoxic agents: Synthesis and Structural Characterization” World Journal of Pharmaceutical Research, 2015, 4(1), 775-782. Impact Factor: 5.99 22.Sreekanth Thota, Srujana Vallala, Rajeshwar Yerra, Eliezer J. Barreiro. Design, Synthesis, Characterization, Cytotoxic and structure activity relationships of novel Ru(II) complexes. Chinese Chemical Letters. 2015, 26, 721-726. Impact Factor: 1.59 23.Shyamsunder Anchuri, Sreekanth Thota. Mononuclear Ru(II) compounds as novel cytotoxic agents. International Journal of Pharmacy and Biological Sciences. 2015, 5(1), 138-144. Impact Factor: 0.56 24. Sreekanth Thota, Anusha Shenkesi, Yerra Rajeshwar. “Design, Synthesis, Spectroscopic characterization and in vitro antineoplastic activities of novel 5- amino-1,3,4-thiadiazole derivatives” Medicinal Chemistry Research, 2015, Article in press. Impact Factor: 1.40 25.Sreekanth Thota, Srujana Vallala, Rajeshwar Yerra, Daniel Alencar Rodrigues, Nulgumnalli Manjunathaiah Raghavendra, Eliezer J. Barreiro. Synthesis,Characterization, DNA binding, DNA cleavage, protein binding and cytotoxic Activities of novel Ru(II) complexes. International Journal of Biological Macromolecule. Accepted September-2015, Article in Press.[Pubmed PMID: 26424207] Impact Factor: 3.016
